This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Sep;38(9):1638-42.

doi: 10.2337/dc15-1380.

Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors

Julio Rosenstock¹, Ele Ferrannini²

Affiliations

Affiliations

¹ Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX juliorosenstock@dallasdiabetes.com.
² Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche, Pisa, Italy.

PMID: 26294774
DOI: 10.2337/dc15-1380

Comment

Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors

Julio Rosenstock et al. Diabetes Care. 2015 Sep.

. 2015 Sep;38(9):1638-42.

doi: 10.2337/dc15-1380.

Authors

Julio Rosenstock¹, Ele Ferrannini²

Affiliations

¹ Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX juliorosenstock@dallasdiabetes.com.
² Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche, Pisa, Italy.

PMID: 26294774
DOI: 10.2337/dc15-1380

No abstract available

PubMed Disclaimer

Comment in

Comment on Rosenstock and Ferrannini. Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors. Diabetes Care 2015;38:1638-1642.
Cushard WG Jr. Cushard WG Jr. Diabetes Care. 2016 Aug;39(8):e138. doi: 10.2337/dc15-1948. Diabetes Care. 2016. PMID: 27457649 No abstract available.
Response to Comment on Rosenstock and Ferrannini. Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors. Diabetes Care 2015;38:1638-1642.
Rosenstock J, Ferrannini E. Rosenstock J, et al. Diabetes Care. 2016 Aug;39(8):e139-40. doi: 10.2337/dci16-0005. Diabetes Care. 2016. PMID: 27457650 No abstract available.

Comment on

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Peters AL, et al. Diabetes Care. 2015 Sep;38(9):1687-93. doi: 10.2337/dc15-0843. Epub 2015 Jun 15. Diabetes Care. 2015. PMID: 26078479 Free PMC article.
Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program.
Erondu N, Desai M, Ways K, Meininger G. Erondu N, et al. Diabetes Care. 2015 Sep;38(9):1680-6. doi: 10.2337/dc15-1251. Epub 2015 Jul 22. Diabetes Care. 2015. PMID: 26203064 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov